U.S. Bioburden Testing Market Size & Outlook, 2025-2030
Related Markets
U.S. bioburden testing market highlights
- The U.S. bioburden testing market generated a revenue of USD 438.2 million in 2024 and is expected to reach USD 918.1 million by 2030.
- The U.S. market is expected to grow at a CAGR of 13.3% from 2025 to 2030.
- In terms of segment, consumables was the largest revenue generating product in 2024.
- Consumables is the most lucrative product segment registering the fastest growth during the forecast period.
Bioburden testing market data book summary
| Market revenue in 2024 | USD 438.2 million |
| Market revenue in 2030 | USD 918.1 million |
| Growth rate | 13.3% (CAGR from 2025 to 2030) |
| Largest segment | Consumables |
| Fastest growing segment | Consumables |
| Historical data | 2018 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Consumables, Instruments |
Other key industry trends
- In terms of revenue, U.S. accounted for 30.4% of the global bioburden testing market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. bioburden testing market is projected to lead the regional market in terms of revenue in 2030.
- Canada is the fastest growing regional market in North America and is projected to reach USD 158.3 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Bioburden Testing Market Scope
Bioburden Testing Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Nelson Laboratories | View profile | 501-1000 | Salt Lake City, Utah, United States, North America | https://www.nelsonlabs.com/ |
| bioMerieux | View profile | 10001+ | Marcy-l'etoile, Rhone-Alpes, France, Europe | http://www.biomerieux.com |
| Pacific BioLabs, Inc. | View profile | 101-250 | Hercules, California, United States, North America | http://pacificbiolabs.com |
| NAMSA | View profile | 1001-5000 | Northwood, Ohio, United States, North America | http://www.namsa.com/ |
| SGS | View profile | 10001+ | Geneva, Geneve, Switzerland, Europe | http://www.sgs.com/ |
| Wuxi AppTec Co Ltd | View profile | 41116 | 288 Fute Zhong Road, Waigaoqiao Free Trade Zone, Shanghai, China, People's Republic of, 200131 | https://www.wuxiapptec.com |
| BD | View profile | 10001+ | Franklin Lakes, New Jersey, United States, North America | https://www.bd.com |
| Charles River Laboratories International Inc | View profile | 21400 | 251 Ballardvale Street, Wilmington, MA, United States, 01887 | https://www.criver.com |
| Thermo Fisher Scientific Inc | View profile | 122000 | 168 Third Avenue, Waltham, MA, United States, 02451 | https://www.thermofisher.com |
| Merck KGaA | View profile | 62345 | Frankfurter Strasse 250, Darmstadt, HE, Germany, 64293 | https://www.emdgroup.com |
U.S. bioburden testing market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to bioburden testing market will help companies and investors design strategic landscapes.
Consumables was the largest segment with a revenue share of 74.49% in 2024. Horizon Databook has segmented the U.S. bioburden testing market based on consumables, instruments covering the revenue growth of each sub-segment from 2018 to 2030.
Reasons to subscribe to U.S. bioburden testing market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of U.S. bioburden testing market databook
-
Our clientele includes a mix of bioburden testing market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. bioburden testing market , including forecasts for subscribers. This country databook contains high-level insights into U.S. bioburden testing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
U.S. bioburden testing market size, by end use, 2018-2030 (US$M)
U.S. Bioburden Testing Market Outlook Share, 2024 & 2030 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
